Symbol="ABOS"
AssetType="Common Stock"
Name="Acumen Pharmaceuticals Inc"
Description="Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies for the treatment of Alzheimer's disease and other neurodegenerative diseases. The company is headquartered in Charlottesville, Virginia."
CIK="1576885"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="427 PARK ST., CHARLOTTESVILLE, VA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="369916000"
EBITDA="-52181000"
PERatio="None"
PEGRatio="None"
BookValue="4.116"
DividendPerShare="0"
DividendYield="0"
EPS="-1.04"
RevenuePerShareTTM="0.033"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.168"
ReturnOnEquityTTM="-0.248"
RevenueTTM="329000"
GrossProfitTTM="-32361000"
DilutedEPSTTM="-1.04"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="15.57"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="538.78"
PriceToBookRatio="1.199"
EVToRevenue="89.67"
EVToEBITDA="-0.908"
Beta="-1.232"
num_52WeekHigh="11.31"
num_52WeekLow="3.52"
num_50DayMovingAverage="6.27"
num_200DayMovingAverage="5.5"
SharesOutstanding="41025100"
DividendDate="None"
ExDividendDate="None"
symbol="ABOS"
open="6.29"
high="6.43"
low="6.21"
price="6.29"
volume="340975.00"
latest_trading_day="2023-08-18"
previous_close="6.40"
change="-0.11"
change_percent="-1.7188%"
aroon_positive_momentum_days="70"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="70"
Volume_recent_avg="758480"
Change_recent_avg="-0.05"
Delta_recent_avg="0.5"
Variance_recent_avg="0.25"
Change_ratio_recent_avg="-0.79"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="70"
Aroon_momentum_negative="30"
image_negative_thumbnail_id_1="1111"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0144.jpeg"
image_negative_thumbnail_id_2="1120"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0153.jpeg"
image_neutral_thumbnail_id_1="556"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_neutral_thumbnail_id_2="534"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_positive_thumbnail_id_1="649"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0059.jpeg"
image_positive_thumbnail_id_2="684"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0024.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
